
Houston Methodist Hospital is the flagship hospital of Houston Methodist. Located in the Texas Medical Center in Houston, Texas, Houston Methodist Hospital was established in 1919 during the height of the Spanish influenza epidemic as an outreach ministry of Methodist Episcopal Church. Houston Methodist comprises seven community hospitals, a continuing care hospital as well as several emergency centers and physical therapy clinics throughout greater Houston. The hospital has consistently ranked as "One of America's Best Hospitals" according to U.S. News and World Report. The hospital has earned worldwide recognition in multiple specialties including cardiovascular surgery, cancer, epilepsy treatment and organ transplantation.Houston Methodist System changed its official name to Houston Methodist in 2013.
Background & objective Consumption of diets insufficient in essential nutrients contributes to unhealthy aging. The objective of this study is to evaluate adequacy of key nutrients that reflect the food components of the Mediterranean-Dietary Approaches to Stop Hypertension Intervention for Neurodegenerative Delay (MIND) dietary pattern, one deemed important for brain health. Setting/design Cross-sectional analyses of diets of participants in the U.S. Study to Protect Brain Health Through Lifestyle Intervention to Reduce Risk (US POINTER) trial Participants Adults, aged 60–79 years and at risk of cognitive impairment (sedentary, suboptimal diet, other risk factors) were enrolled in the US POINTER, a phase III two-year randomized controlled trial comparing the impact of two lifestyle interventions on brain health. Measurements Before randomization, participants completed a food frequency questionnaire (FFQ) assessing usual intake of foods and beverages, and vitamin and/or mineral supplements. Median daily nutrient intakes were expressed as a percentage of sex- and age-specific Estimated Average Requirement (EAR) or Adequate Intake (AI), and Tolerable Upper Limit (UL) criteria. Results Of the 2111 enrolled participants, 2041 completed the FFQs (69% women). Nearly half reported multivitamin multimineral supplement use (49%, men; 49%, women). Common individual supplements included vitamins D (36%), E (25%), C (23%), and B12 (19%) as well as calcium (16%). Based on food alone, the proportion of participants with inadequate intakes was high across several nutrients. Supplements improved nutrient adequacy for most (except for choline, fiber and potassium) but contributed to intakes for some that exceed the UL cutoffs (vitamins A (n=28), B9 (n=134), B3 (n=160) and zinc (n=196)). Conclusions Widespread nutrient inadequacy (especially those integral to the MIND dietary pattern) is evident among non-supplement users. Supplement use improves adequacy but raises concerns about excessive intakes that exceed ULs. Assessment of diet and supplement intake is essential to address nutrient inadequacies in at-risk older adults. Clinical Trial Registration Number : NCT03688126, submitted 9/26/2018.
Objective This study, titled the ViTAA Case Review Program, aimed at evaluating the influence of the ViTAA Regional Aortic Weakness (RAW) Maps software on clinical decision-making in the management of abdominal aortic aneurysms (AAA). The purpose was twofold: first, to determine the impact of RAW Maps on projected patient care decisions compared with the standard of care approach, and second, to train investigators in the effective use of ViTAA RAW Maps for AAA assessment. This paper offers a case series focusing on the experience of participating surgeons in using the ViTAA RAW Maps software. Methods Fifteen North American vascular surgeons participated and were provided with fully anonymized static and multiphase gated computed tomography angiography (CTA) scans obtained from a previous retrospective study. Five cases were selected from a single site and for each, participating physicians developed hypothetical treatment plans based on two imaging approaches: static CTA scans and multiphase gated CTA scans processed with the ViTAA RAW Maps software. These treatment plans were then compared to determine the impact of the ViTAA approach on clinical decision-making. Results The ViTAA approach supported significantly higher surgical intervention rates compared with the standard of care, with vascular surgeons being 69% (P < .05) and 88% (P < .01) more likely to recommend surgery (either endovascular or open repair) at baseline and follow-up, respectively. The proportion of cases in which the recommendation changed when the ViTAA analysis was provided was 18.9% at baseline (95% confidence interval, 10.0-35.8) and 28.0% at follow-up (95% confidence interval, 19.1-41.0). ViTAA also prompted more endovascular aneurysm repair (72% more at baseline and 57% more at follow-up; P = .065 and P = .057, respectively), as well as increased fenestrated endovascular aneurysm repair (6.8% vs 2.7% at baseline and 11% vs 7% at follow-up; not statistically significant, P = .25 and P = .38, respectively). Across the 10 questionnaire items, 73% to 100% of participating physicians responded favorably to questions regarding the functionality and utility of the software. Conclusions This study suggests that ViTAA technology may provide additional information for AAA risk stratification by incorporating functional image-derived biomechanical and hemodynamic metrics that offer deeper insight into aortic wall vulnerability. The participating physicians found these additional insights clinically meaningful, with the potential to influence management decisions for the reviewed cases. The usability of the software also suggests feasible integration into future workflows.
Gastric cancer (GC) remains a major global health burden, with poor survival rates. HER2 is a key biomarker for targeted therapy, but discordance between primary tumors and metastases may impact treatment decisions. This meta-analysis evaluated the prevalence and clinical relevance of HER2 status differences between primary gastric cancers and metastatic lesions. A systematic search of PubMed, Embase, and Cochrane was conducted for studies assessing HER2 status in matched primary and metastatic gastric cancer samples. Pooled proportions and 95
Sex disparities in left ventricular assist device (LVAD) therapy remain a significant challenge in advanced heart failure care. This review synthesizes evidence on differences in epidemiology, clinical presentation, anatomical suitability, complications, and long-term recovery to clarify why women remain underrepresented despite comparable survival with contemporary devices. Women constitute nearly half of the heart failure population but only 20–25
Cells can recover from sub-lethal necrosis by repairing plasma-membrane (PM) rupture through the ESCRT-III machinery, but how this process is regulated remains unknown. Here, we identify Toll-interacting protein (Tollip) as a conserved negative regulator for ESCRT-III–mediated PM repair. Quantitative proteomics revealed the enrichment of Tollip at damaged PM. Additionally, microscopy assays in mammalian cells and C. elegans confirmed the recruitment of Tollip to PM injury sites. Tollip deficiency augmented ESCRT-III assembly, improved long-term cell survival after sub-lethal PM damage, and enhanced PM repair, whereas Tollip overexpression suppressed these processes. Tollip translocation occurred independently of Ca2⁺ influx, different from ESCRT-III. Functionally, by limiting PM repair and maintaining sub-lethal PM integrity loss, Tollip ensured optimal chemokine and cytokine production from the plasma-membrane-integrity (PMI) pathway, which is directly triggered by PM ruptures. Thus, Tollip acts as a molecular rheostat that links membrane damage repair and cell recovery to immune signaling.